Japan says in deal to purchase AstraZeneca's Covid-19 vaccine | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Wednesday
September 27, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
WEDNESDAY, SEPTEMBER 27, 2023
Japan says in deal to purchase AstraZeneca's Covid-19 vaccine

Coronavirus chronicle

Reuters
07 August, 2020, 03:35 pm
Last modified: 07 August, 2020, 04:26 pm

Related News

  • South Korea, Japan, China agree to hold summit at 'earliest convenient time'
  • After US approval, Japan okays its first Alzheimer's drug
  • Social media inspires Japanese women to dash into rickshaw pulling
  • China willing to work with South Korea ahead of summit with Japan: Xi
  • Bangladesh needs multiple choices for better bargaining in foreign financial proposals: Japanese expert

Japan says in deal to purchase AstraZeneca's Covid-19 vaccine

The agreement comes after Japan announced a deal last week to buy 120 million doses of a Covid-19 vaccine candidate developed by Pfizer Inc and BioNTech SE

Reuters
07 August, 2020, 03:35 pm
Last modified: 07 August, 2020, 04:26 pm
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, April 28, 2014. REUTERS/Stefan Wermuth/File Photo
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, April 28, 2014. REUTERS/Stefan Wermuth/File Photo

Japan will buy 120 million doses of AstraZeneca Plc's experimental Covid-19 vaccine from early next year, its health minister said on Friday, adding that domestic pharmaceutical firms would help in supplying the drug.

The agreement with the British drugmaker comes after Japan announced a deal last week to buy 120 million doses of a Covid-19 vaccine candidate developed by Pfizer Inc and BioNTech SE.

"I understand one or two doses are effective per person," Health Minister Katsunobu Kato told reporters.

"If each person receives two injections, this would cover 60 million people."

Japan is the latest country to sign up for AstraZeneca's vaccine, known as AZD1222, which is under development in partnership with the University of Oxford. The pharmaceutical firm has been in talks with Russia, Brazil and others about supply deals for its potential vaccine.

In a statement, AstraZeneca said it would produce the vaccine substance in Japan with JCR Pharmaceuticals Co, while also importing additional substance from overseas.

Daiichi Sankyo Ltd, Daiichi Sankyo Biotech Co, Meiji Seika Pharma Co and KM Biologics Co will support supply in Japan, the company said.

As Japan procures vaccines from abroad, it is also developing its own vaccine for the novel coronavirus, with AnGes Inc and Osaka University working on a DNA vaccine, while Shionogi & Co is working on a recombinant protein type.

The University of Tokyo and Daiichi Sankyo are developing an mRNA version.

There are currently no approved vaccines or treatments for the illness caused by the new coronavirus, but about a dozen vaccines from more than 100 candidates globally are being tested in humans.

Japan / AstraZeneca

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Foreign Minister Dr AK Abdul Momen speaking at a views-exchange meeting organised by the Bangabandhu Foundation in New York's Bangladeshi-dominated Jackson Heights on 26 September. Photo: UNB
    Bangladesh-US ties 'outstandingly cordial' but some trying to inject bitterness: Momen
  • Tourism master plan aims to attract 5.57m tourists annually by 2041
    Tourism master plan aims to attract 5.57m tourists annually by 2041
  • Bangladesh Nationalist Party (BNP) Secretary General Mirza Fakhrul Islam Alamgir. File Photo: UNB
    Bangladesh in dire state: Mirza Fakhrul

MOST VIEWED

  • US dollar banknotes are seen in this illustration taken on 10 March 2023. Photo: Reuters
    Taka weakens even further
  • The Fitch Ratings logo is seen at their offices at Canary Wharf financial district in London,Britain, March 3, 2016. REUTERS/Reinhard Krause
    Fitch now rates Bangladesh's foreign debt outlook negative
  • Experts say Dhaka has at least 18 times more than the population it can actually support. Photo: Rajib Dhar
    DAP relaxes floor area ratio, planners raise concerns over Dhaka's livability
  • Bangladesh Bank Governor Abdur Rouf Talukder. Photo: Collected
    Global Finance's report card: Why Bangladesh Bank governor got D. Who got A+?
  • US dollar banknotes are seen in this illustration taken on 10 March 2023. Photo: Reuters
    Cenbank unaware of US restriction on ACU, seeks info from RBI
  • Why Biman struggles to overcome pilot shortage
    Why Biman struggles to overcome pilot shortage

Related News

  • South Korea, Japan, China agree to hold summit at 'earliest convenient time'
  • After US approval, Japan okays its first Alzheimer's drug
  • Social media inspires Japanese women to dash into rickshaw pulling
  • China willing to work with South Korea ahead of summit with Japan: Xi
  • Bangladesh needs multiple choices for better bargaining in foreign financial proposals: Japanese expert

Features

More than 86 lakh Bangladeshis went abroad as migrant workers in the last 14 years, according to BMET (Bureau of Manpower, Employment and Training). Naturally, these workers return to Bangladesh at some point to settle down. Photo: Syed Zakir Hossain

Why migrant workers have a hard time back at home

7h | Panorama
What impact will a forward forex rate have?

What impact will a forward forex rate have?

8h | Panorama
India-Canada clash should be a wakeup call

India-Canada clash should be a wakeup call

1d | Panorama
It is highly unlikely that inflation rate is going to come down soon. PHOTO: TBS

No more central bank loans to the govt: Will it be enough to curb inflation?

1d | Panorama

More Videos from TBS

Nafees Iqbal removed from team role on Shakib's request

Nafees Iqbal removed from team role on Shakib's request

1h | TBS SPORTS
Fitch rates Bangladesh's foreign debt outlook negative

Fitch rates Bangladesh's foreign debt outlook negative

4h | TBS Economy
How dependent is Canada's economy on India?

How dependent is Canada's economy on India?

20h | TBS World
IMEC; Is the main objective to stop China?

IMEC; Is the main objective to stop China?

19h | TBS World
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]